Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients

Some COVID-19 patients suffer complications from anti-viral immune responses which can lead to both a dangerous cytokine storm and development of blood-borne factors that render severe thrombotic events more likely. The precise immune response profile is likely, therefore, to determine and predict p...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Eid, Rasha, Ward, Frank James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Immunological Societies. Published by Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457906/
https://www.ncbi.nlm.nih.gov/pubmed/34562551
http://dx.doi.org/10.1016/j.imlet.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457906/
https://www.ncbi.nlm.nih.gov/pubmed/34562551
http://dx.doi.org/10.1016/j.imlet.2021.09.005

Ejemplares similares